Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs STMicroelectronics NV — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B), while STMicroelectronics NV trades at $52.06 (market cap $48.14B). The key difference: STMicroelectronics NV is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and STMicroelectronics NV for 64 Days on average.
| RPRX | STM | |
|---|---|---|
Market Cap | $25.27B | $48.14B |
Volume | 3,671,183 | 9,776,015 |
Sector | Health | Technology |
52-Week High | $63.96 | $79.91 |
52-Week Low | $35.44 | $21.20 |
Typical Hold Time | 1 Days | 64 Days |
Enterprise Value | $32.50B | $45.66B |
Dividend Yield | 1.66% | 0.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
STM (STMicroelectronics) is trading at $52.71, down 6.18% over the past 24 hours amid a broader tech selloff. The stock shows mixed signals with a bearish technical outlook but positive analyst sentiment, including a consensus price target of $77.31. Recent financials reveal declining revenue and negative net income margins, though strong cash flow and a solid balance sheet provide stability. Key developments include growing AI data-center revenue projections and new product launches in automotive sensing.
The outlook for STM hinges on execution in AI and automotive segments, with potential upside from analyst targets. Risks include margin pressure from fab transitions and macroeconomic volatility. Investors should weigh strong institutional support against near-term profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
